Go or no go on EU medtech reforms?
This article was originally published in SRA
Executive Summary
With less than a month to go before Latvia hands over the presidency of the Council of the EU to Luxembourg, there is intense interest over whether member states as represented on the council will reach agreement before then on the changes they want to make to the European Commission’s proposals for new medical device and in vitro diagnostic legislation.